Labiana |
6 March
Labiana is publishing an informative guide to help its shareholders understand how subscription rights work and the different alternatives available during the capital increase.
Labiana |
26 February
Labiana Health has been recognized as a success story on BME Growth by Bolsas y Mercados Españoles (BME), which highlights the company’s evolution since its IPO and its growth as a pharmaceutical group specializing in human and animal health, being the first veterinary pharmaceutical laboratory to be listed on the stock exchange in Spain.
Labiana |
19 February
Labiana Health has secured €37 million in syndicated financing and will execute a pre-emptive capital increase. The transaction enhances its credit profile and supports organic and inorganic growth.
Labiana |
28 November
Labiana has completed the validation of the analytical methods for cannabis flowers intended for therapeutic use according to the European Pharmacopoeia. This allows the company to certify producers or distributors worldwide that their batches comply with the specifications required by current regulations.
Labiana |
28 October
Labiana, the pharmaceutical laboratory specializing in animal and human health and listed on BME Growth, will bring its new line of products for women’s health and wellness to CPHI, the most important annual trade fair in the pharmaceutical sector, taking place from October 28 to 30 in Germany.
Specifically, Labiana — which specializes in the development and manufacturing of both its own products and those for third parties (CDMO) — will present, as part of its human health portfolio, two food supplements and one cosmetic product.
Labiana |
9 September
In recent years, medicinal cannabis has attracted significant interest within the medical and scientific communities. The most studied and recognized compounds of this plant are tetrahydrocannabinol (THC) and cannabidiol (CBD), both of which possess important therapeutic properties. However, terpenes—also present in cannabis—have begun to gain relevance in research due to their potential effects on the modulation and synergy with cannabinoids. This article explores the role of terpenes within the context of medicinal cannabis, highlighting their importance in the development of new treatments.
